Literature DB >> 19691043

Sex-specific association of the Reelin gene with bipolar disorder.

F S Goes1, V L Willour1, P P Zandi1,2, P L Belmonte1, D F MacKinnon1, F M Mondimore1, B Schweizer1, J R DePaulo1, E S Gershon3, F J McMahon4, J B Potash1.   

Abstract

The Reelin gene (RELN) encodes a secretory glycoprotein critical for brain development and synaptic plasticity. Post-mortem studies have shown lower Reelin protein levels in the brains of patients with schizophrenia and bipolar disorder (BP) compared with controls. In a recent genome-wide association study of schizophrenia, the strongest association was found in a marker within RELN, although this association was seen only in women. In this study, we investigated whether genetic variation in RELN is associated with BP in a large family sample. We genotyped 75 tagSNPs and 6 coding SNPs in 1,188 individuals from 318 nuclear families, including 554 affected offspring. Quality control measures, transmission-disequilibrium tests (TDTs), and empirical simulations were performed in PLINK. We found a significant overtransmission of the C allele of rs362719 to BP offspring (OR = 1.47, P = 5.9 x 10(-4)); this withstood empirical correction for testing of multiple markers (empirical P = 0.048). In a hypothesis-driven secondary analysis, we found that the association with rs362719 was almost entirely accounted for by overtransmission of the putative risk allele to affected females (OR(Female) = 1.79, P = 8.9 x 10(-5) vs. OR(Male) = 1.12, P = 0.63). These results provide preliminary evidence that genetic variation in RELN is associated with susceptibility to BP and, in particular, to BP in females. However, our findings should be interpreted with caution until further replication and functional assays provide convergent support. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19691043      PMCID: PMC3032172          DOI: 10.1002/ajmg.b.31018

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  35 in total

1.  Reelin promoter hypermethylation in schizophrenia.

Authors:  Dennis R Grayson; Xiaomei Jia; Ying Chen; Rajiv P Sharma; Colin P Mitchell; Alessandro Guidotti; Erminio Costa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-16       Impact factor: 11.205

2.  Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder.

Authors:  Marin Veldic; Bashkim Kadriu; Ekrem Maloku; Roberto C Agis-Balboa; Alessandro Guidotti; John M Davis; Erminio Costa
Journal:  Schizophr Res       Date:  2007-01-31       Impact factor: 4.939

3.  Reproductive cycle-associated mood symptoms in women with major depression and bipolar disorder.

Authors:  Jennifer L Payne; Patricia S Roy; Kathleen Murphy-Eberenz; Myrna M Weismann; Karen L Swartz; Melvin G McInnis; Eva Nwulia; Francis M Mondimore; Dean F MacKinnon; Erin B Miller; John I Nurnberger; Douglas F Levinson; J Raymond DePaulo; James B Potash
Journal:  J Affect Disord       Date:  2006-10-02       Impact factor: 4.839

4.  Reelin modulates NMDA receptor activity in cortical neurons.

Authors:  Ying Chen; Uwe Beffert; Mert Ertunc; Tie-Shan Tang; Ege T Kavalali; Ilya Bezprozvanny; Joachim Herz
Journal:  J Neurosci       Date:  2005-09-07       Impact factor: 6.167

5.  Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population.

Authors:  P A Thomson; N R Wray; J K Millar; K L Evans; S Le Hellard; A Condie; W J Muir; D H R Blackwood; D J Porteous
Journal:  Mol Psychiatry       Date:  2005-07       Impact factor: 15.992

Review 6.  Reelin, lipoprotein receptors and synaptic plasticity.

Authors:  Joachim Herz; Ying Chen
Journal:  Nat Rev Neurosci       Date:  2006-11       Impact factor: 34.870

7.  Genomic organization of the mouse reelin gene.

Authors:  I Royaux; C Lambert de Rouvroit; G D'Arcangelo; D Demirov; A M Goffinet
Journal:  Genomics       Date:  1997-12-01       Impact factor: 5.736

Review 8.  Carving chaos: genetics and the classification of mood and psychotic syndromes.

Authors:  James B Potash
Journal:  Harv Rev Psychiatry       Date:  2006 Mar-Apr       Impact factor: 3.732

Review 9.  Reelin glycoprotein: structure, biology and roles in health and disease.

Authors:  S H Fatemi
Journal:  Mol Psychiatry       Date:  2005-03       Impact factor: 15.992

Review 10.  G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis.

Authors:  Sevilla D Detera-Wadleigh; Francis J McMahon
Journal:  Biol Psychiatry       Date:  2006-04-11       Impact factor: 13.382

View more
  19 in total

Review 1.  MicroRNA-132, -134, and -138: a microRNA troika rules in neuronal dendrites.

Authors:  Silvia Bicker; Martin Lackinger; Kerstin Weiß; Gerhard Schratt
Journal:  Cell Mol Life Sci       Date:  2014-07-10       Impact factor: 9.261

2.  Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder.

Authors:  Jack Samuels; Ying Wang; Mark A Riddle; Benjamin D Greenberg; Abby J Fyer; James T McCracken; Scott L Rauch; Dennis L Murphy; Marco A Grados; James A Knowles; John Piacentini; Bernadette Cullen; O Joseph Bienvenu; Steven A Rasmussen; Daniel Geller; David L Pauls; Kung-Yee Liang; Yin Y Shugart; Gerald Nestadt
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-03-28       Impact factor: 3.568

3.  Assessment of Whole-Exome Sequence Data in Attempted Suicide within a Bipolar Disorder Cohort.

Authors:  Eric T Monson; Mehdi Pirooznia; Jennifer Parla; Melissa Kramer; Fernando S Goes; Marie E Gaine; Sophia C Gaynor; Kelly de Klerk; Dubravka Jancic; Rachel Karchin; W Richard McCombie; Peter P Zandi; James B Potash; Virginia L Willour
Journal:  Mol Neuropsychiatry       Date:  2017-01-18

4.  Neuronal Heterotopias Affect the Activities of Distant Brain Areas and Lead to Behavioral Deficits.

Authors:  Kazuhiro Ishii; Ken-ichiro Kubo; Toshihiro Endo; Keitaro Yoshida; Seico Benner; Yukiko Ito; Hidenori Aizawa; Michihiko Aramaki; Akihiro Yamanaka; Kohichi Tanaka; Norio Takata; Kenji F Tanaka; Masaru Mimura; Chiharu Tohyama; Masaki Kakeyama; Kazunori Nakajima
Journal:  J Neurosci       Date:  2015-09-09       Impact factor: 6.167

5.  Sex differences in disease risk from reported genome-wide association study findings.

Authors:  Linda Y Liu; Marc A Schaub; Marina Sirota; Atul J Butte
Journal:  Hum Genet       Date:  2011-08-20       Impact factor: 4.132

Review 6.  Genomics and pharmacogenomics of schizophrenia.

Authors:  Ramón Cacabelos; Rocío Martínez-Bouza
Journal:  CNS Neurosci Ther       Date:  2010-08-16       Impact factor: 5.243

7.  Genetic variants in the RELN gene are associated with otosclerosis in multiple European populations.

Authors:  Isabelle Schrauwen; Megan Ealy; Erik Fransen; Kathleen Vanderstraeten; Melissa Thys; Nicole C Meyer; Marcel Cosgarea; Alex Huber; Manuela Mazzoli; Markus Pfister; Richard J H Smith; Guy Van Camp
Journal:  Hum Genet       Date:  2009-10-22       Impact factor: 4.132

Review 8.  The involvement of Reelin in neurodevelopmental disorders.

Authors:  Timothy D Folsom; S Hossein Fatemi
Journal:  Neuropharmacology       Date:  2012-09-07       Impact factor: 5.250

9.  Convergent Lines of Evidence Support LRP8 as a Susceptibility Gene for Psychosis.

Authors:  Ming Li; Liang Huang; Maria Grigoroiu-Serbanescu; Sarah E Bergen; Mikael Landén; Christina M Hultman; Andreas J Forstner; Jana Strohmaier; Julian Hecker; Thomas G Schulze; Bertram Müller-Myhsok; Andreas Reif; Philip B Mitchell; Nicholas G Martin; Sven Cichon; Markus M Nöthen; Anna Alkelai; Bernard Lerer; Stéphane Jamain; Marion Leboyer; Frank Bellivier; Bruno Etain; Jean-Pierre Kahn; Chantal Henry; Marcella Rietschel
Journal:  Mol Neurobiol       Date:  2015-12-04       Impact factor: 5.590

10.  Overexpression of Reelin prevents the manifestation of behavioral phenotypes related to schizophrenia and bipolar disorder.

Authors:  Cátia M Teixeira; Eduardo D Martín; Ignasi Sahún; Nuria Masachs; Lluís Pujadas; André Corvelo; Carles Bosch; Daniela Rossi; Albert Martinez; Rafael Maldonado; Mara Dierssen; Eduardo Soriano
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.